http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014127712-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014127712-A |
| titleOfInvention | Phenylpyrrole derivative |
| abstract | 1. The compound represented by formula (I) where Q refers to a group represented by the following formula (A) or (B) R is hydroxyl, C-Salkoxy or NRR, each of R and R, which may be the same or different, represents a hydrogen atom , C-C1-6alkyl or C-Cycloalkyl, or R and R are bonded together with the adjacent nitrogen atom to form a 3-7 membered saturated heterocyclic ring (wherein the saturated heterocyclic ring is optionally substituted with one or two C-C1-6 alkyls); R represents a hydrogen atom, a halogen atom or C -Salki l; n is 1 or 2; R represents a hydrogen atom, a halogen atom or C 1-6 alkyl; R 1 represents C 1-6 alkyl (C 1-6 alkyl may be substituted with one or 2 C 1-6 cycloalkyls) or C 1-6 cycloalkyl 1 C 2 -cycloalkyl may be substituted one or two C-C1-6alkyls); each of R and R, which may be the same or different, is C-C1-6alkyl or C-Cycloalkyl, or R and R are bonded together with the adjacent nitrogen atom to form a 3-7 membered saturated heterocyclic ring (wherein saturated the heterocyclic ring is optionally substituted with one or two with C-C1-6alkyls)] or a pharmaceutically acceptable salt thereof. 2. A compound according to claim 1, wherein Q is a group of formula (A) (wherein R is as defined in claim 1), or a pharmaceutically acceptable salt thereof. A compound according to claim 1 or 2, wherein R 1 is NRR (where R 1 and R 1 are as defined in 1), or a pharmaceutically acceptable salt thereof. A compound according to claim 1 or 2, wherein each of R and R represents a hydrogen atom and n is 1, or a pharmaceutically acceptable salt thereof. A compound according to claim 3, wherein each of R and R is a hydrogen atom and n is 1, or a pharmaceutically acceptable salt thereof. A compound according to claim 1 or 2, wherein R 1 is |
| priorityDate | 2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.